Skincare is entering a more evidence-focused phase, as consumers and brands increasingly look for ingredients, formulations and claims supported by research rather than novelty alone.
Across Asia-Pacific, beauty is becoming more closely connected with health, functionality and long-term skin wellbeing. Mintel’s 2026 Asia-Pacific beauty landscape identifies evidence-based longevity actives, wellbeing science and clinic-adjacent innovation as major opportunity areas, including new actives, delivery systems and formats.
From Ingredient Buzz to Evidence
The science-backed movement is not necessarily about finding a completely new ingredient. Established actives such as retinoids, vitamin C and peptides are being developed in more sophisticated formulations and delivery systems. 2026 skincare trend reporting points to brands refining these familiar ingredients while placing greater emphasis on clinical evidence and measurable outcomes.
This is changing how consumers evaluate products. Ingredient lists remain important, but shoppers are increasingly interested in what an ingredient is intended to do, how it is delivered and what evidence supports the finished formula.
